Metabolix to make bioplastics in Iowa

Esposito, Frank
April 2016
Plastics News;4/4/2016, Vol. 28 Issue 5, p0022
Trade Publication
The article reports on the agreement signed by materials firm Metabolix with agricultural firm CJ CheilJedang Corp. in 2016 to build a plant making Mirel-brand polyhydroxyalkanoate (PHA) bioresins in Fort Dodge, Iowa. Topics covered include the expected annual production capacity of the plant, the engineering capabilities and operating expertise that will be brought by CJ to the project and the deal signed by Metabolix with Antibiotics SA to make PHA at a plant in Spain.


Related Articles

  • RiPro80, Riber50 Offer Rice Bran Protein, Fiber.  // Today's Dietitian;Dec2010, Vol. 12 Issue 12, p48 

    The article offers brief information on the RiPro80 rice bran protein and Riber50 rice bran fiber from CJ CheilJedang Corp.

  • Arkema and CJ officially launch the start of the construction of their Bio-Methionine and Thiochemicals complex in Malaysia.  // Chemical Business;Oct2012, Vol. 26 Issue 10, p61 

    The article reports that Arkema SA and CJ Cheiljedang Corp. have officially started the construction of a Bio-Methionine plant and Thiochemicals Platform in Kerteh in Malaysia.

  • Methionine gets bio treatment.  // TCE: The Chemical Engineer;May2011, Issue 839, p16 

    The article reports on the partnership between CJ Cheiljedang (CJ Group) and chemicals company Arkeman to construct a methionine plant either in Malaysia and Thailand which will use plant-based raw materials.

  • Arkema and CJ's Thiochemicals Platform Inaugurated.  // Chemical Engineering World;Jun2015, Vol. 50 Issue 6, p14 

    The article focuses on the inauguration of the joint thiochemicals plant of chemical firm Arkema and bio business CJ CheilJedang in Terengganu, Malaysia in 2015 in which His Royal Highness the Sultan of Terengganu and the Federal and State Government authorities of Malaysia were invited.

  • KERTEH TO BE A MAJOR THIOCHEMICALS SITE FOR AKEMA. ALPEROWICZ, NATASHA // Chemical Week;8/15/2011, Vol. 173 Issue 20, p17 

    The article reports on the decision made by Arkema and CJ Cheil-Jedang to select Kerteh, Malaysia as the site of their bio-methionine and thiochemicals complex.

  • RM7b FDI aim for Kemaman.  // Malay Mail;9/28/2012, p18 

    The article reports that the 1,000-hectare Kerteh BioPolymer Park (KBP) in Kemaman, Malaysia is expected to attract several global biotechnology players, like South Korea's CJ CheilJedang Corp. and France's Arkema, with anticipated foreign direct investment worth 7-billion Malaysian rupiahs by 2015.

  • Arkema and CJ break ground for bio-methionine complex in Malaysia.  // Chemical Week;10/15/2012, Vol. 174 Issue 26, p16 

    The article discusses a bio-methionine and thiochemical plant being built by the chemical company Arkema and the holding company CJ CheilJedang, focusing on a 2012 groundbreaking ceremony.

  • Somaxon and CJ CheilJedang Announce Silenor(r) Collaboration in South Korea.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article provides information on the collaboration between Somaxon Pharmaceuticals Inc. and CJ CheilJedang Corp. Under the collaboration CJ CheilJedang will commercialize Silenor(®) (doxepin) for the treatment of insomnia in South Korea. Under the terms of the agreements, Somaxon will...

  • Mobile office solutions draw interest amid slowdown.  // NetworkWorld Asia;Oct/Nov2009, Vol. 5 Issue 5, p33 

    The article focuses on the development of mobile office solutions by SK Telecom Co. Ltd. which include groupware, electronic mail services, unified communications and fixed-mobile convergence (FMC). It is claimed that real-time services from SK Telecom Co. Ltd. are adopted by companies which...

  • Deals Roundup.  // BioWorld Today;1/15/2008, Vol. 19 Issue 10, p5 

    The article reports on a deal signed by Forticell Bioscience Inc. granting CJ CheilJedang exclusive right for a limited time to use its Fibrin MicroBeads technology for the extraction and expansion of mesenchymal-type stem cells from human umbilical cord blood. Forticell subsidiary Hapto Biotech...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics